The first Aeglea BioTherapeutics trade was made in Q1 2017. Since then Jim Simons bought shares thirteen more times and sold shares on thirteen occasions. The investor sold all their shares in Q3 2023 and doesn't own any shares in Aeglea BioTherapeutics anymore.